Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
作者信息
Salvesen C, Vaksdal K
出版信息
Behav Neuropsychiatry. 1973;5(7-12):3-7.
PMID:4154740
Abstract
摘要
相似文献
1
2
[Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].[在后续护理单元使用长效抗精神病药物的经验。以棕榈酸哌泊噻嗪为例的治疗组织]
Tidsskr Nor Laegeforen. 1973 Aug 30;93(24):1699-703.
3
A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.棕榈酸哌泊噻嗪治疗慢性精神分裂症的长期试点研究。
Curr Ther Res Clin Exp. 1972 Nov;14(11):696-706.
4
Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.用棕榈酸哌泊噻嗪对慢性精神分裂症门诊患者进行每月一次的间歇性化疗。
Can Psychiatr Assoc J. 1974 Dec;19(6):583-91. doi: 10.1177/070674377401900608.
5
6
Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Acta Psychiatr Scand. 1973;49(5):563-9. doi: 10.1111/j.1600-0447.1973.tb04447.x.
7
Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
Acta Psychiatr Scand Suppl. 1973;241:83-94. doi: 10.1111/j.1600-0447.1973.tb07046.x.
8
[Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
J Med Lyon. 1972 Apr 20;53(227):591-8.
9
Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.棕榈酸哌泊噻嗪（19.552 R.P.）在北欧国家的临床经验。一项多中心调查的报告。
Acta Psychiatr Scand Suppl. 1973;241:51-6. doi: 10.1111/j.1600-0447.1973.tb07042.x.
10
Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
Acta Psychiatr Scand Suppl. 1973;241:75-82. doi: 10.1111/j.1600-0447.1973.tb07045.x.
Zotero 插件